Insecticides (India) Limited has informed the Exchange regarding Outcome of Board Meeting held on May 28, 2026.
INSECTICID · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Insecticides (India) Limited reported audited FY2026 standalone revenue of Rs 2,14,001 lakhs, up ~7% from Rs 1,99,995 lakhs in FY2025. However, standalone profit before tax declined to Rs 18,198 lakhs from Rs 19,028 lakhs last year. Profit after tax remained flat at Rs 13,972 lakhs. Basic EPS declined slightly to Rs 46.68 from Rs 47.61. The auditors gave an unmodified (clean) opinion on both standalone and consolidated financial statements. Key board decisions include formulation of Employee Stock Purchase Scheme 2026 (up to 2 lakh shares), resignation of Mrs. Nikunj Aggarwal as Whole Time Director, appointment of Mr. Sanskar Aggarwal as Whole Time Director (Additional) for 5 years, and appointment of M/s T Jain & Associates as Internal Auditor. The 29th AGM will be held on August 12, 2026.
The 7% revenue growth was offset by lower profitability, indicating margin compression. The clean audit and leadership succession are neutral to positive. The ESPS scheme could be dilutive to shareholders pending AGM approval.